IHU INFINY - Institut des Maladies Inflammatoires Chroniques de l'Intestin
The IHU model represents an innovative approach to medical research, education, and patient care, bringing together multidisciplinary teams of experts from various fields to work collaboratively towards a common goal
IHUs are pivotal in harnessing the objectives of the France 2030 policy by propelling transformative advances in healthcare and accelerating medical innovation
Integrating research, patient care, education, clinical excellence, and innovation, INFINY Institute aims to help patients live normal lives, reduce diagnosis delays, and ultimately work toward a cure and the eradication of the disease.
This collaborative approach is vital in addressing complex and prevalent health conditions, such as inflammatory bowel disease (IBD), which requires a comprehensive and multidisciplinary strategy.
IHU INFINY was founded through the collaborative efforts of its four founding members: the University Hospital of Nancy, the University of Lorraine, INSERM, and the Metropole du Grand Nancy, under the visionary leadership of Professor Laurent PEYRIN-BIROULET.
www.chu-nancy.fr
www.univ-lorraine.fr
www.inserm.fr
www.grandnancy.eu
-
Secteur
-
Services de recherche
-
Taille de l’entreprise
-
51-200 employés
-
Siège social
-
Nancy
-
Type
-
Société cotée en bourse
-
Fondée en
-
2023
-
Domaines
-
IBD et MICI